Almirall delivered net sales growth of 12.4% in 2025, surpassing [...]

Abivax has presented new preclinical and clinical data for obefazimod [...]

Long-term VIVID-2 data show more than 90% of patients with [...]

The inaugural International Brain Health Conference 2026 in Edinburgh will [...]

Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]

Lario Therapeutics awarded $2.4M by The Michael J. Fox Foundation [...]

Evinova has announced collaborations with Astellas Pharma, AstraZeneca and Bristol [...]

Affibody has reported positive Phase 1 data from its licensee [...]

Sensei Biotherapeutics has acquired Faeth Therapeutics and announced a concurrent [...]

Polaryx Therapeutics, Inc has selected a leading contract research organization [...]